Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Koolen

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 13, 2016
Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trialMichael Haude, Raimund Erbel, Paul Erne, et al.
Lancet (London, England)|January 22, 2013
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trialMichael Haude, Raimund Erbel, Paul Erne, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 20, 2018
Invasive cardiovascular needs in South Africa: a view from afar up closeDavid R Holmes, Spencer King, Anthony H Gershlick, et al.
Circulation. Cardiovascular Interventions|February 26, 2020
Mechanism of Drug-Eluting Absorbable Metal Scaffold Restenosis: A Serial Optical Coherence Tomography StudyYasushi Ueki, Lorenz Räber, Tatsuhiko Otsuka, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2013
Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMISorin J Brener, Jan-Henk Dambrink, Akiko Maehara, et al.
Circulation. Cardiovascular Interventions|November 21, 2013
Serial observation of drug-eluting absorbable metal scaffold: multi-imaging modality assessmentRon Waksman, Francesco Prati, Nico Bruining, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 25, 2014
Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMISorin J Brener, Jan-Henk Dambrink, Akiko Maehara, et al.
European Heart Journal|May 13, 2005
Angiographic, intravascular ultrasound, and fractional flow reserve evaluation of direct stenting vs. conventional stenting using BeStent2 in a multicentre randomized trialWilliam Wijns, Stefan Verheye, Ganesh Manoharan, et al.
Journal of the American College of Cardiology|May 29, 2007
Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER StudyNico H J Pijls, Pepijn van Schaardenburgh, Ganesh Manoharan, et al.
Journal of the American Heart Association|May 31, 2021
Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer-Generation Drug-Eluting StentsRayyan Hemetsberger, Mohammad Abdelghani, Ralph Toelg, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 13, 2016
Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trialMichael Haude, Raimund Erbel, Paul Erne, et al.
Lancet (London, England)|January 22, 2013
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trialMichael Haude, Raimund Erbel, Paul Erne, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 20, 2018
Invasive cardiovascular needs in South Africa: a view from afar up closeDavid R Holmes, Spencer King, Anthony H Gershlick, et al.
Circulation. Cardiovascular Interventions|February 26, 2020
Mechanism of Drug-Eluting Absorbable Metal Scaffold Restenosis: A Serial Optical Coherence Tomography StudyYasushi Ueki, Lorenz Räber, Tatsuhiko Otsuka, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2013
Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMISorin J Brener, Jan-Henk Dambrink, Akiko Maehara, et al.
Circulation. Cardiovascular Interventions|November 21, 2013
Serial observation of drug-eluting absorbable metal scaffold: multi-imaging modality assessmentRon Waksman, Francesco Prati, Nico Bruining, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 25, 2014
Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMISorin J Brener, Jan-Henk Dambrink, Akiko Maehara, et al.
European Heart Journal|May 13, 2005
Angiographic, intravascular ultrasound, and fractional flow reserve evaluation of direct stenting vs. conventional stenting using BeStent2 in a multicentre randomized trialWilliam Wijns, Stefan Verheye, Ganesh Manoharan, et al.
Journal of the American College of Cardiology|May 29, 2007
Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER StudyNico H J Pijls, Pepijn van Schaardenburgh, Ganesh Manoharan, et al.
Journal of the American Heart Association|May 31, 2021
Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer-Generation Drug-Eluting StentsRayyan Hemetsberger, Mohammad Abdelghani, Ralph Toelg, et al.
Pageof 6